ResMed Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Unlock the Full Value Chain Analysis for Deeper Insight
This ResMed Value Chain Analysis gives you a clear, structured view of how ResMed creates value across its support and primary activities. The page already shows a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to access the complete ready-to-use report.
Support Activities
Firm Infrastructure
ResMed's firm infrastructure is built around regulated medical-device and software governance, quality systems, finance, legal, and compliance. In FY2025, ResMed reported revenue of about $5.1 billion, so this layer has to support scale without slipping on FDA, EU MDR, HIPAA, and cybersecurity rules. That matters because ResMed sells across 140+ countries and manages multiple product lines at once.
Human Resource Management
In FY2025, ResMed generated about US$5.1 billion in revenue and employed roughly 11,000 people, so hiring quality directly supports scale. ResMed depends on engineers, clinical experts, manufacturing staff, regulatory specialists, and software talent because it must combine medtech discipline with cloud-software skills in a tightly regulated field. Training matters too, since ResMed's product mix spans devices, digital health, and connected care, where small talent gaps can slow launches or compliance.
Technology Development
ResMed's technology development centers on device design, mask innovation, and cloud tools like AirView and myAir, which support remote monitoring and better therapy adherence. In fiscal 2025, ResMed reported about $5.2 billion in revenue and invested roughly 7% of sales in research and development, helping refresh CPAP, ventilator, and software products faster. That spend also supports data analytics that improves care delivery and keeps switching costs high.
Procurement
ResMed's procurement depends on tightly qualified suppliers for medical-grade plastics, silicone, electronics, sensors, packaging, and contract manufacturing inputs. In fiscal 2025, with revenue above US$5 billion, this control matters because any defect or shortage can hit output, margins, and device quality fast in a sensor-heavy medtech chain.
ResMed's support engine powered a US$5.1B global medtech platform
ResMed's support activities kept a US$5.1 billion FY2025 business running across 140+ countries by tightening compliance, finance, and quality systems. Its ~11,000 employees backed regulated medtech work in engineering, clinical, software, and operations. R&D stayed near 7% of sales, supporting device, mask, and digital tools. Procurement stayed disciplined across plastics, silicon, electronics, and contract manufacturing.
| FY2025 metric | ResMed |
|---|---|
| Revenue | US$5.1 billion |
| Employees | ~11,000 |
| R&D intensity | ~7% of sales |
| Market reach | 140+ countries |
What is included in the product
Detailed Word Document
Editable Excel File
Primary Activities
Inbound Logistics
In FY2025, ResMed reported revenue of US$5.1 billion, and its inbound logistics had to keep regulated parts, masks, ventilator subassemblies, and software-enabled hardware flowing without delays. Careful inventory planning and supplier traceability matter here because medical-device quality rules are strict and any break can hit output. That discipline helps ResMed keep production steady while supporting its 58.6% FY2025 gross margin.
Operations
ResMed's operations cover design, assembly, testing, and validation of CPAP machines, masks, ventilators, and respiratory software, with quality and cybersecurity controls built in. In FY2025, ResMed reported revenue of about $5.1 billion, showing the scale that its repeatable manufacturing and validation process supports. Its high-margin model also showed up in FY2025 gross margin near 59%, which points to efficient production and tight quality control.
Outbound Logistics
In FY2025, ResMed reported US$5.1 billion in revenue, so outbound logistics has a direct link to scale and service. ResMed moves masks, replacement parts, and devices through regional warehouses, direct fulfillment, distributors, DMEs, homecare channels, and hospital customers, which helps keep patient supply lines moving across global markets. Fast, reliable delivery matters because resupply timing affects adherence, and ResMed served millions of patients worldwide in 2025.
Marketing and Sales
ResMed's marketing and sales model runs through clinicians, sleep labs, DMEs, hospitals, and health systems, while also pushing patient awareness for sleep apnea treatment. In FY2025, revenue reached about $5.1 billion, and the mix still relied on device adoption, recurring mask and supply replenishment, plus software subscriptions that help keep customers tied to its platform.
Service
ResMed's service layer covers onboarding, device setup, mask-fit help, remote monitoring via AirView and myAir, plus technical and warranty support. In FY2025, ResMed reported about $5.1 billion in revenue, and this post-sale support helps drive adherence and repeat purchases in a chronic-care market with ongoing replacement cycles.
Better service also lowers churn for patients and providers by fixing issues early and keeping therapy on track.
ResMed's FY2025 engine drove US$5.1B revenue and 58.6% gross margin
ResMed's primary activities in FY2025 turned US$5.1 billion revenue into scale through regulated sourcing, device and mask manufacturing, and strict quality checks.
It then used regional warehouses and direct fulfillment to ship devices, masks, and spare parts across DME, hospital, and homecare channels.
Clinician-led sales, AirView and myAir support, and warranty service help drive adherence, repeat supply sales, and a 58.6% gross margin.
| FY2025 | Data |
|---|---|
| Revenue | US$5.1B |
| Gross margin | 58.6% |
Full Version Awaits
ResMed Reference Sources
You're previewing the actual ResMed Value Chain Analysis document you'll receive after purchase – no sample, no filler. The full report is professionally structured and ready to use, with the complete version unlocked immediately after checkout. This is the same file customers download, just shown here in preview form.
Frequently Asked Questions
ResMed's strongest support comes from technology development and regulated infrastructure. The company combines devices, software, and clinical data workflows across 140+ countries, so quality systems, cybersecurity, and product engineering are core advantages. That structure supports 2 revenue engines-hardware and software-and helps scale chronic-care relationships.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.